148 related articles for article (PubMed ID: 38418135)
1. The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer.
Otani K; Aoyama T; Maezawa Y; Hashimoto I; Kamiya N; Kato A; Numata M; Kawahara S; Tamagawa A; Nakazono M; Tamagawa H; Segami K; Kazama K; Sawazaki S; Yukawa N; Saito A; Rino Y
In Vivo; 2024; 38(2):897-903. PubMed ID: 38418135
[TBL] [Abstract][Full Text] [Related]
2. Modified neutrophil-platelet score as a promising marker for stratified surgical and oncological outcomes of patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Omura Y; Kusunoki K; Yin C; Ide S; Kitajima T; Koike Y; Fujikawa H; Yasuda H; Okita Y; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Surg Today; 2020 Mar; 50(3):223-231. PubMed ID: 31485750
[TBL] [Abstract][Full Text] [Related]
3. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
4. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
5. The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
7. The hematologic inflammatory index is a new prognostic marker in patients resected for gastric cancer.
Sahinli H; Türker S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S144-S149. PubMed ID: 33380669
[TBL] [Abstract][Full Text] [Related]
8. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: A propensity score matching analysis.
Matsui R; Inaki N; Tsuji T
Clin Nutr; 2021 May; 40(5):2745-2753. PubMed ID: 33933740
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study.
Matsumoto T; Ohki S; Kaneta A; Matsuishi A; Maruyama Y; Yamada L; Tada T; Hanayama H; Watanabe Y; Hayase S; Okayama H; Sakamoto W; Momma T; Saze Z; Kono K
BMC Surg; 2023 Jan; 23(1):8. PubMed ID: 36635689
[TBL] [Abstract][Full Text] [Related]
11. Comparing prognostic value of preoperative platelet indexes in patients with resectable gastric cancer.
Shi H; Wang H; Pan J; Liu Z; Li Z
Sci Rep; 2022 Apr; 12(1):6480. PubMed ID: 35444195
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer.
Guo L; Wang Q; Chen K; Liu HP; Chen X
J Gastrointest Surg; 2021 Oct; 25(10):2470-2483. PubMed ID: 33575904
[TBL] [Abstract][Full Text] [Related]
13. High postoperative neutrophil-lymphocyte ratio and low preoperative lymphocyte-monocyte ratio predict poor prognosis in gastric cancer patients receiving gastrectomy with positive lavage cytology: a retrospective cohort study.
Sato S; Kunisaki C; Takahashi M; Kubo H; Tsuchiya N; Sato K; Miyamoto H; Tamura Y; Kondo H; Tanaka Y; Kasahara K; Kosaka T; Akiyama H; Saigusa Y; Endo I
Langenbecks Arch Surg; 2021 Nov; 406(7):2295-2303. PubMed ID: 34137915
[TBL] [Abstract][Full Text] [Related]
14. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
Urabe M; Yamashita H; Watanabe T; Seto Y
World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
[TBL] [Abstract][Full Text] [Related]
17. Postoperative Prolonged Inflammatory Response as a Poor Prognostic Factor After Curative Resection for Gastric Cancer.
Okumura Y; Hiki N; Kumagai K; Ida S; Nunobe S; Ohashi M; Sano T
World J Surg; 2017 Oct; 41(10):2611-2618. PubMed ID: 28451762
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of preoperative prognostic nutritional index in resected advanced gastric cancer: A multicenter propensity score analysis.
Luo Z; Zhou L; Balde AI; Li Z; He L; ZhenWei C; Zou Z; Huang S; Han S; Wei Zhou M; Zhang GQ; Cai Z
Eur J Surg Oncol; 2019 Mar; 45(3):425-431. PubMed ID: 30366877
[TBL] [Abstract][Full Text] [Related]
19. Non-linear association between long-term outcome and preoperative neutrophil-to-lymphocyte ratio in patients undergoing curative resection for gastric cancer: a retrospective analysis of 1335 cases in a tetrachotomous manner.
Urabe M; Yamashita H; Uemura Y; Tanabe A; Yagi K; Aikou S; Seto Y
Jpn J Clin Oncol; 2018 Apr; 48(4):343-349. PubMed ID: 29420755
[TBL] [Abstract][Full Text] [Related]
20. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
